高级检索
    白春梅, 黄凌. 西妥昔单抗治疗进展性结直肠癌的疗效与KRAS基因突变状态的关系[J]. 循证医学, 2009, 9(3): 144-146. DOI: 10.3969/j.issn.1671-5144.2009.03.015
    引用本文: 白春梅, 黄凌. 西妥昔单抗治疗进展性结直肠癌的疗效与KRAS基因突变状态的关系[J]. 循证医学, 2009, 9(3): 144-146. DOI: 10.3969/j.issn.1671-5144.2009.03.015
    shu
    BAI Chun-mei, HUANG Ling. KRAS Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 144-146. DOI: 10.3969/j.issn.1671-5144.2009.03.015
    Citation: BAI Chun-mei, HUANG Ling. KRAS Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2009, 9(3): 144-146. DOI: 10.3969/j.issn.1671-5144.2009.03.015
    shu

    西妥昔单抗治疗进展性结直肠癌的疗效与KRAS基因突变状态的关系

    KRAS Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回